Xtreme-ProteX DGH Pharma

Wales, United Kingdom Healthcare, Pharma, Medical, Pathogens, MRSA

Short Summary

World Class and Market Leading, DGH Pharma’s Patented and Patent Pending Xtreme-ProteX Hand and Mask Sanitizing Solutions Kills Pathogens, Bacteria and Viruses for 4 hours plus (industry standard 20 seconds).

Highlights

  • A scientifically proven, continuous 4+ hour kill rate against pathogens
  • Patent and Patent Pending Technologies are essence of these products
  • Proven Team
  • Market Appetite for deliverable solutions
  • NHS Targeted Area

Overview

Target
£1,000,000
Minimum
£100,000
Invested
n/a
Previous Rounds n/a
Stage Finished Product
Investor Role n/a
Please Note: Investments of this nature carry risks to your capital as well as potential rewards. Please read our Risk Warning and Disclaimer before deciding to invest.

Sign up or log in now

Sign up now to gain full access to pitches and investor profiles

global:publish_msg_immediate




global:publish_msg



Congratulations!


You have passed the test and you may continue your with your investment.